More yard-sale scavenging by PFE—22 generic drugs bought from AKRX for $35M in cash: http://finance.yahoo.com/news/Akorn-Announces-the-Sale-of-bw-3624137736.html?x=0&.v=1 Sixteen of the drugs are approved in the US and six have pending ANDAs.